Form 8-K - Current report:
SEC Accession No. 0001641172-25-020580
Filing Date
2025-07-22
Accepted
2025-07-22 16:30:38
Documents
15
Period of Report
2025-06-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 49312
2 EX-10.1 ex10-1.htm EX-10.1 208213
3 EX-10.2 ex10-2.htm EX-10.2 16573
  Complete submission text file 0001641172-25-020580.txt   536004

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE celu-20250623.xsd EX-101.SCH 3891
5 XBRL DEFINITION FILE celu-20250623_def.xml EX-101.DEF 26798
6 XBRL LABEL FILE celu-20250623_lab.xml EX-101.LAB 37062
7 XBRL PRESENTATION FILE celu-20250623_pre.xml EX-101.PRE 25422
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6104
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 251140619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)